Abstract:What is known and objective: Linezolid, a member of the oxazolidinone class of antibacterial drugs, is approved by the US Food and Drug Administration (FDA) for the treatment of vancomycin-resistant Enterococcus faecium infections, nosocomial and community-acquired pneumonia, as a part of anti tubercular regimen and complicated and uncomplicated skin and soft tissue infections, including diabetic foot infections. Linezolid has potential adverse effects like bone marrow suppression, peripheral neuropathy and hyponatremia. One of the extremely rare reported adverse effects of the drug is hypoglycaemia. We present a case of Linezolid toxicity presenting as resistant hypoglycemia, bone marrow suppression and severe hyponatremia all together in a single patient. Case description: We present a case of an 82 years old gentleman with no known chronic co-morbidities. He was started on Linezolid 600 mg twice a day for 10 days by a local doctor possibly for some minor infection post hip surgery. He was in respiratory distress on arrival. Blood sugars showed severe hypoglycemia of 36 mg/dL (2.0 mmol/L). He was admitted in intensive care unit and started on injectable antibiotics and 5% dextrose infusion and sugars were strictly monitored. His blood tests revealed severe hyponatremia with sodium level of 119 mEq/L and haemoglobin (Hb) of 8.8 gm/dL, leucocytes of 6500/µL, platelets of 82 000/µL. The infection markers were normal throughout. The platelet count went progressively down from 82 000/µL on admission to 20 000/µL 2 days later; before it started rising back. Similarly there was drop in Hemoglobin and white cell counts. He required vasopressors to maintain mean arterial pressures. The blood sugar levels stabilized after the same. However patient had suffered acute lung injury secondary to aspiration and became NIV dependent and eventually passed away. What is new and conclusion: Our case was unique in a way that our patient had adverse effects of linezolid like myelosuppression as well as the rare side effects of hypoglycemia at the same time. This combination of adverse events has never been described in the past to our knowledge. All the adverse effects responded to antibiotic de-challenge in our case. We had ruled out the possibility of other causes of Hypoglycemia such as sepsis, insulinoma, alcohol excess, malnutrition or hypoadrenalism. We searched the PubMed database and found four case reports out of which two were diabetics and other two were non diabetics. Out of 15 cases described by Vishwanathan et al only three cases were non diabetics. Our patient was non diabetic as well. Therefore our case is only the sixth reported case of hypoglycemia in non diabetic receiving Linezolid to our knowledge.

Linezolid-induced black hairy tongue

Oral Bacteria Dysbiosis in Patients with Linezolid-Induced Black Hairy Tongue: A Case Series

A Case Report of a Co-Amoxiclav-Induced Black Hairy Tongue

The clinical features and drug resistance of 10 patients with linezolid-nonsusceptible Enterococcal blood stream infection

Black Tongue: A Rare Presentation of Rhupus Syndrome

Anti-Helicobacter Pylori Infection Treatment and Pulmonary Hypersensitivity: Case Series and Review of the Literature

Case Report: A case study and literature review on teeth discoloration caused by linezolid with the shortest incubation period in a pediatric patient

Impact of prolonged treatment with linezolid on the human gut flora

Linezolid-induced rare triad of hypoglycaemia, bone marrow suppression and hyponatraemia in elderly

Erysipelothrix rhusiopathiae bacteremia treated with linezolid

Bacillus As a Potential Diagnostic Marker for Yellow Tongue Coating

Analysis of the Effect Factors of Thrombocytopenia Associated with Linezolid

High frequency of thrombocytopenia in patients with acute-on-chronic liver failure treated with linezolid

Citalopram-Induced Oral Melanotic Macules in a Female Patient and a Review of the Literature

Linezolid induced lactic acidosis in tuberculosis: a systematic review of published case reports, case series

Fluoroquinolone-resistant latent tuberculosis infection: a literature review and case series of 5 patients treated with linezolid monotherapy

[Lichenoid drug eruption with antituberculosis drugs associated with an anonychia]

Mechanisms of Linezolid Resistance in Mycobacteria

Reversible recurrent profound thrombocytopenia due to linezolid in a patient with multi-drug resistant tuberculosis: A case report.

Association of pharmacokinetic and pharmacodynamic aspects of linezolid with infection outcome

Successful treatment of linezolid-induced severe lactic acidosis with continuous venovenous hemodiafiltration: A case report